Skip to search formSkip to main contentSkip to account menu

CI 920

Known as: CI-920 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

fostriecin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Studies on the biochemical mechanism of the novel antitumor agent, CI-920
SummaryBiochemical studies on a new antitumor antibiotic, CI-920, have been directed toward understanding its mode of action. The… 
2004
2004
Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days
Fostriecin (CI-920) is a potent inhibitor of protein phosphatase 2A (PP2A) and protein phosphatase 4(PP4) found to have… 
2002
2002
Total synthesis of fostriecin (CI-920) via a convergent route.
Fostriecin, a potent and promising antitumor antibiotic, was stereoselectively synthesized via a convergent route involving a… 
Highly Cited
2001
Highly Cited
2001
Total Synthesis of Fostriecin (CI‐920)
Fostriecin (CI-920, 1; see Scheme 1) is a structurally interesting antitumor agent that was first isolated in 1983 by scientists… 
1995
1995
Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
1990
1990
Antitumor activity of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenyl-pyrido [3,4-b]pyrazin-7-ylcarbamate, 2-hydroxyethanesulfonate, hydrate (NSC 370147) against selected tumor systems in culture and in…
Ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin- 7-ylcarbamate, 2-hydroxyethanesulfonate, hydrate (NSC 370147… 
1989
1989
Cardiotropic activity of pyridin-2(1H)-ones
Recent years have seen the introduction into clinical practice for the treatment of cardiac insufficiency of new cardiotonic… 
1986
1986
Antimycotic effects of the novel antitumor agents fostriecin (CI-920), PD 113,270 and PD 113,271.
The novel fermentation products fostriecin and analogs PD 113,270 and PD 113,271 are structurally related polyene lactone… 
1986
1986
Use of CI-920 in the characterization of the methotrexate transport defects in a resistant human leukemic CCRF-CEM cell line
1985
1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)